TRIAL  PHASE  CONTACT  LOCATION
 Phase I/II Study of Lenalidomide Maintenance Following BEAM (+/- Rituximab) for Chemo-Resistant or High Risk Non-Hodgkin's Lymphoma  I/II  

Coordinator:

MAILLIARD, MARY

 Nebraska Medical Center, Omaha, NE
 A Phase II Study of Dasatinib (SPRYCEL) (IND #73969, NSC #732517) as Primary Therapy Followed by Transplantation for Adults  = 50 Years, with Newly Diagnosed PH+ Acute Lymphoblastic Leukemia by CALGB, ECOG, SWOG and NCIC CTG (CALGB 10701)  II

Coordinator:

HOYT, ROSE

 Nebraska Medical Center, Omaha, NE
 Phase II Study of Reduced-Intensity Allogeneic Stem Cell Transplant for High-Risk Chronic Lymphocytic Leukemia (CLL) (CALGB 100701-02)  II

Coordinator:

HARDIMAN, PENNY

 Nebraska Medical Center, Omaha, NE
 

AAML05P1, Killer Immunoglobulin-Like Receptor (KIR) Incompatible Unrelated Donor Hematopoietic Stem Cell Transplantation (SCT) for AML with Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory and Relapsed Acute Myelogenous Leukemia (AML) in Children: A Children's Oncology Group (COG) Study

   

Coordinator:

OLSON, TAMRA

 Nebraska Medical Center, Omaha, NE
 Defibrotide for Hematopoietic Stem Cell Transplant (SCT) Patient with Severe Hepatic Veno Occlusive Disease (VOD): A Treatment IND Study    

Coordinator:

HARDIMAN, PENNY

 Nebraska Medical Center, Omaha, NE
 A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia  III  

Coordinator:

HARDIMAN, PENNY

 Nebraska Medical Center, Omaha, NE
 A Phase ll/lll Randomized, Multicenter Trial Comparing Sirolimus Plus Prednisone, and Sirolimus/Calcineurin Inhibitor Plus Prednisone for the Treatment of Chronic Versus-Host Disease  II/III  

Coordinator:

HARDIMAN, PENNY

 Nebraska Medical Center, Omaha, NE
 Phase lll Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma  III HARDIMAN, PENNY  Nebraska Medical Center, Omaha, NE

Nebraska Oncology Society
c/o Nebraska Medical Association
Sarah Dunbar
Executive Director
233 South 13th Street Suite 1200
Lincoln, NE 68508
sarahd@nebmed.org (email)
402-474-4472 (phone)
402-474-2198 (fax)

Powered by Wild Apricot Membership Software